Magellan Health (MGLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Sales | 445,890 | 433,231 | 437,066 | 437,919 | 444,842 |
| Gross Profit | 445,890 | 433,231 | 437,066 | 437,919 | N/A |
| Operating Expenses | 405,813 | 413,488 | 406,357 | 406,744 | 0 |
| Operating Income | 40,077 | 19,743 | 30,709 | 31,175 | N/A |
| Interest Expense | 24,323 | 24,818 | 24,625 | 24,434 | 22,409 |
| Other Income | -1,769 | -415,110 | -147 | 2,017 | 37,251 |
| Pre-tax Income | 13,985 | -420,185 | 5,937 | 8,758 | 14,842 |
| Income Tax | 3,129 | 139,304 | 2,581 | 3,638 | 6,086 |
| Net Income Continuous | 10,829 | -559,517 | 3,383 | 5,090 | 8,740 |
| Net Income Discontinuous | 900 | 1,673 | 926 | 1,225 | 978 |
| Net Income | $11,729 | $-557,844 | $4,309 | $6,315 | $N/A |
| EPS Basic Total Ops | 0.29 | -15.94 | 0.09 | 0.14 | -5.28 |
| EPS Basic Continuous Ops | 0.27 | -15.99 | 0.06 | 0.11 | 0.22 |
| EPS Basic Discontinuous Ops | 0.02 | 0.05 | 0.03 | 0.03 | 0.03 |
| EPS Diluted Total Ops | 0.28 | -15.94 | 0.08 | 0.14 | -4.32 |
| EPS Diluted Continuous Ops | 0.26 | -15.99 | 0.06 | 0.11 | 0.21 |
| EPS Diluted Discontinuous Ops | 0.02 | 0.05 | 0.02 | 0.03 | 0.02 |
| EBITDA(a) | $-397,791 | $448,671 | $31,711 | $53,493 | $444,842 |